Senate committee advances pharma patent challenge billnews2024-11-22T17:19:17+00:00November 22nd, 2024|Endpoints News|
From vaccines to psychedelics, five drugmakers on what could change under a Trump administrationnews2024-11-22T16:25:09+00:00November 22nd, 2024|Endpoints News|
Halozyme withdraws €2B Evotec acquisition proposalnews2024-11-22T15:30:47+00:00November 22nd, 2024|Endpoints News|
Lexicon ends commercial work to focus on R&Dnews2024-11-22T15:23:01+00:00November 22nd, 2024|Endpoints News|
With yearslong reorganization behind it, Novartis increases its sales guidancenews2024-11-21T21:27:52+00:00November 21st, 2024|Endpoints News|
Jazz wins approval for bispecific in biliary tract cancernews2024-11-21T19:17:39+00:00November 21st, 2024|Endpoints News|
Trump and RFK Jr. want to ban pharma ads. History isn’t on their sidenews2024-11-21T16:59:15+00:00November 21st, 2024|Endpoints News|
FDA vaccine chief Peter Marks pledges to stay as long as he’s welcomenews2024-11-21T15:46:12+00:00November 21st, 2024|Endpoints News|
Amgen names geneticist and biotech founder to CSO postnews2024-11-21T03:39:23+00:00November 21st, 2024|Endpoints News|
NewAmsterdam aces Phase 3 trial, but investors are skepticalnews2024-11-20T21:18:34+00:00November 20th, 2024|Endpoints News|
